公司资料
FEMASYS 股价、新闻与催化剂
- 股票代码:
- FEMY
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
2.16 USD (-5.68%)
收盘价
最后更新: 2026年8月17日
22.4M USD
市值
股价为何变动
Following the latest company update, “Femasys Announces Financial Results for Quarter Ended June 30, 2026 and Provides Corporate Update”, FEMY closed down 5.68% at $2.16 on Aug 17, 2026. The move occurred in the trading session associated with this earnings update.
公司概览
业务概览
Femasys is a women’s health medical technology company focused on fertility and reproductive-health products. Its business is centered on procedures and devices that address unmet needs in women’s health.
所在地与行业分类
Femasys is headquartered in the United States and listed on NASDAQ. It sits in women’s-health medtech rather than biotechnology.
商业模式特征
The company depends on product adoption, physician acceptance, and regulatory or commercial milestones. Investors watch launch execution, reimbursement, and the pace of market penetration.
生物医药行业定位
Femasys occupies a women’s-health device niche within healthcare innovation. It is not biotech proper, but its growth still depends on product adoption and clinical credibility.
未来催化剂
- Femasys’s catalysts are FemBloc commercialization and women’s-health product development, where adoption and regulatory progress matter most. The company needs to show the platform can translate into real clinical use.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。